Adrian Woolfson
2019
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $207,100 |
| Option Awards | $1,498,175 |
| Salary | $449,732 |
| Other | $5,503 |
| Total | $2,310,510 |
Woolfson received $1.5M in option awards, accounting for 65% of the total pay in 2019.
Woolfson also received $150K in bonus, $207.1K in non-equity incentive plan, $449.7K in salary and $5.5K in other compensation.
Rankings
In 2019, Adrian Woolfson's compensation ranked 5,216th out of 13,971 executives tracked by ExecPay. In other words, Woolfson earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,216 out of 13,971 | 63rd |
Division Manufacturing | 1,941 out of 5,701 | 66th |
Major group Chemicals And Allied Products | 682 out of 2,200 | 69th |
Industry group Drugs | 573 out of 1,886 | 70th |
Industry Biological Products, Except Diagnostic Substances | 130 out of 389 | 67th |
Pay ratio
| Adrian Woolfson's Pay | $2,310,510 |
|---|---|
| Median Employee's Pay | $159,900 |
| Pay Ratio | 14to 1 |
In 2019, the annual total compensation of Adrian Woolfson was $2,310,510.
The annual total compensation of the median employee at Sangamo Biosciences was $159,900.
The ratio of Adrian Woolfson's pay to the pay of median employee was therefore 14 to one.
Woolfson's colleagues
We found six more compensation records of executives who worked with Adrian Woolfson at Sangamo Biosciences in 2019.
2019
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2019
Sung Lee
Sangamo Biosciences
Chief Financial Officer
2019
Gary Loeb
Sangamo Biosciences
General Counsel
2019
Stéphane Boissel
Sangamo Biosciences
Chief Financial Officer
2019
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
2019
Kathy Yi
Sangamo Biosciences